NEW YORK, April 26, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today ...
The Texas Vaccine Policy Symposium, hosted by Rice University’s Baker Institute for Public Policy Nov. 15, will discuss the impact of vaccines in Texas and the challenges ahead as experts look toward ...
SAN DIEGO, March 03, 2025 (GLOBE NEWSWIRE) -- DIOSynVax, a clinical-stage biotechnology company specializing in AI-leveraged vaccines has used this innovative technology to develop a pan-bird-flu ...
A short educational session on the human papillomavirus (HPV) vaccine improved vaccination willingness among women with autoimmune rheumatic diseases.
A nurse prepares children for a polia vaccine shot as part of a city-wide testing of the vaccine on elementary school students. As students across the country shoulder backpacks and file into ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results